Green Cross constructing $255m Canadian immunoglobulin and albumin plant 09-Jun-2015 By Dan Stanton Green Cross Biotherapeutics has begun constructing a facility in Canada it says will produce up to five tons of injectable antibodies and 25,000kg of albumin annually.
Duck cells for Ebola vaccine production: ProBioGen highlights Emergent's use of tech for MVA EBOZ 09-Jun-2015 By Gareth Macdonald Emergent Biosolutions’ Ebola vaccine is the first to be made in cells rather than the hens’ eggs according to production tech developer ProBioGen.
Single-use demonstration sites 'needed more than ever' says Sartorius 09-Jun-2015 By Dan Stanton Sartorius says application centres are integral to demonstrate its single-use technologies as it opens a third in New York.
